BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $856M (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 40.7%

Value $348M Shares 10,799,410 Est. Cost $8.21 Unrealized +310.5%

MNST MONSTER BEVERAGE CORP NEW 30.6%

Value $262M Shares 4,656,488 Est. Cost $22.71 Unrealized +41.5%

IWM ISHARES TR 14.8%

Value $127M Shares 1,110,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 6.3%

Value $53.79M Shares 760,062 Est. Cost $27.50 Unrealized +172.3%

— ONCOCYTE CORPORATION 3.9%

Value $33.48M Shares 13,666,204 Est. Cost $3.22 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS IN 3.3%

Value $28.16M Shares 34,005,379 Est. Cost $1.03 Unrealized -3.4%

— AGEX THERAPEUTICS INC 0.3%

Value $2.787M Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,799,410	$348M	40.7%	$8.21	+310.5%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$262M	30.6%	$22.71	+41.5%	COM	61174X109
IWM	ISHARES TR	1,110,000	$127M	14.8%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$53.79M	6.3%	$27.50	+172.3%	COM	05464C101
—	ONCOCYTE CORPORATION	13,666,204	$33.48M	3.9%	$3.22	—	COM	68235C107
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$28.16M	3.3%	$1.03	-3.4%	COM	53566P109
—	AGEX THERAPEUTICS INC	2,997,156	$2.787M	0.3%	$2.99	—	COM	00848H108